BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 38627145)

  • 1. The immunodominance of antigenic site Sb on the H1 influenza virus hemagglutinin increases with high immunoglobulin titers of the cohorts and with young age, but not sex.
    Martínez JL; Lemus N; Lai TY; Mishra M; González-Domínguez I; Puente-Massaguer E; Loganathan M; Francis B; Samanovic MI; Krammer F; Mulligan MJ; Simon V; Palese P; Sun W
    Vaccine; 2024 May; 42(14):3365-3373. PubMed ID: 38627145
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunodominance of Antigenic Site B in the Hemagglutinin of the Current H3N2 Influenza Virus in Humans and Mice.
    Broecker F; Liu STH; Sun W; Krammer F; Simon V; Palese P
    J Virol; 2018 Oct; 92(20):. PubMed ID: 30045991
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antigenic sites in influenza H1 hemagglutinin display species-specific immunodominance.
    Liu STH; Behzadi MA; Sun W; Freyn AW; Liu WC; Broecker F; Albrecht RA; Bouvier NM; Simon V; Nachbagauer R; Krammer F; Palese P
    J Clin Invest; 2018 Nov; 128(11):4992-4996. PubMed ID: 30188868
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influenza Virus Hemagglutinin Stalk-Specific Antibodies in Human Serum are a Surrogate Marker for
    Jacobsen H; Rajendran M; Choi A; Sjursen H; Brokstad KA; Cox RJ; Palese P; Krammer F; Nachbagauer R
    mBio; 2017 Sep; 8(5):. PubMed ID: 28928215
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minor changes in the hemagglutinin of influenza A(H1N1)2009 virus alter its antigenic properties.
    Strengell M; Ikonen N; Ziegler T; Julkunen I
    PLoS One; 2011; 6(10):e25848. PubMed ID: 22022458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunodominance hierarchy after seasonal influenza vaccination.
    Sánchez-de Prada L; Sanz-Muñoz I; de Lejarazu RO; Eiros JM; García-Sastre A; Aydillo T
    Emerg Microbes Infect; 2022 Dec; 11(1):2670-2679. PubMed ID: 36219456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibody Responses toward the Major Antigenic Sites of Influenza B Virus Hemagglutinin in Mice, Ferrets, and Humans.
    Sun W; Kang DS; Zheng A; Liu STH; Broecker F; Simon V; Krammer F; Palese P
    J Virol; 2019 Jan; 93(2):. PubMed ID: 30381487
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-Linked Glycans and K147 Residue on Hemagglutinin Synergize To Elicit Broadly Reactive H1N1 Influenza Virus Antibodies.
    Huang Y; Owino SO; Crevar CJ; Carter DM; Ross TM
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31852790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mapping of a Novel H3-Specific Broadly Neutralizing Monoclonal Antibody Targeting the Hemagglutinin Globular Head Isolated from an Elite Influenza Virus-Immunized Donor Exhibiting Serological Breadth.
    Qiu Y; Stegalkina S; Zhang J; Boudanova E; Park A; Zhou Y; Prabakaran P; Pougatcheva S; Ustyugova IV; Vogel TU; Mundle ST; Oomen R; Delagrave S; Ross TM; Kleanthous H; Qiu H
    J Virol; 2020 Feb; 94(6):. PubMed ID: 31826999
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epitope mapping of the hemagglutinin molecule of A/(H1N1)pdm09 influenza virus by using monoclonal antibody escape mutants.
    Matsuzaki Y; Sugawara K; Nakauchi M; Takahashi Y; Onodera T; Tsunetsugu-Yokota Y; Matsumura T; Ato M; Kobayashi K; Shimotai Y; Mizuta K; Hongo S; Tashiro M; Nobusawa E
    J Virol; 2014 Nov; 88(21):12364-73. PubMed ID: 25122788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Responses to the Sb epitope contributed to antigenic drift of the influenza A 2009 H1N1 virus.
    Ketklao S; Boonarkart C; Phakaratsakul S; Auewarakul P; Suptawiwat O
    Arch Virol; 2020 Nov; 165(11):2503-2512. PubMed ID: 32783078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of Novel Cross-Reactive Influenza B Virus Hemagglutinin Head Specific Antibodies That Lack Hemagglutination Inhibition Activity.
    Kirkpatrick E; Henry C; McMahon M; Jiang K; Strohmeier S; van Bakel H; Wilson PC; Krammer F
    J Virol; 2020 Nov; 94(23):. PubMed ID: 32907980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B cell response and hemagglutinin stalk-reactive antibody production in different age cohorts following 2009 H1N1 influenza virus vaccination.
    Sangster MY; Baer J; Santiago FW; Fitzgerald T; Ilyushina NA; Sundararajan A; Henn AD; Krammer F; Yang H; Luke CJ; Zand MS; Wright PF; Treanor JJ; Topham DJ; Subbarao K
    Clin Vaccine Immunol; 2013 Jun; 20(6):867-76. PubMed ID: 23576673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum strain-specific or cross-reactive neuraminidase inhibiting antibodies against pandemic А/California/07/2009(H1N1) influenza in healthy volunteers.
    Desheva YA; Smolonogina TA; Donina SA; Rudenko LG
    BMC Res Notes; 2015 Apr; 8():136. PubMed ID: 25889924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential Effects of Prior Influenza Exposures on H3N2 Cross-reactivity of Human Postvaccination Sera.
    Xie H; Li L; Ye Z; Li X; Plant EP; Zoueva O; Zhao Y; Jing X; Lin Z; Kawano T; Chiang MJ; Finch CL; Kosikova M; Zhang A; Zhu Y; Wan XF
    Clin Infect Dis; 2017 Jul; 65(2):259-267. PubMed ID: 28369230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sera from Individuals with Narrowly Focused Influenza Virus Antibodies Rapidly Select Viral Escape Mutations
    Davis AKF; McCormick K; Gumina ME; Petrie JG; Martin ET; Xue KS; Bloom JD; Monto AS; Bushman FD; Hensley SE
    J Virol; 2018 Oct; 92(19):. PubMed ID: 30045982
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunodominance and Antigenic Variation of Influenza Virus Hemagglutinin: Implications for Design of Universal Vaccine Immunogens.
    Zost SJ; Wu NC; Hensley SE; Wilson IA
    J Infect Dis; 2019 Apr; 219(Suppl_1):S38-S45. PubMed ID: 30535315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A human monoclonal antibody derived from a vaccinated volunteer recognizes heterosubtypically a novel epitope on the hemagglutinin globular head of H1 and H9 influenza A viruses.
    Boonsathorn N; Panthong S; Koksunan S; Chittaganpitch M; Phuygun S; Waicharoen S; Prachasupap A; Sasaki T; Kubota-Koketsu R; Yasugi M; Ono K; Arai Y; Kurosu T; Sawanpanyalert P; Ikuta K; Watanabe Y
    Biochem Biophys Res Commun; 2014 Sep; 452(3):865-70. PubMed ID: 25204499
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epitope mapping of the 2009 pandemic and the A/Brisbane/59/2007 seasonal (H1N1) influenza virus haemagglutinins using mAbs and escape mutants.
    Retamal M; Abed Y; Corbeil J; Boivin G
    J Gen Virol; 2014 Nov; 95(Pt 11):2377-2389. PubMed ID: 25078301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel correlates of protection against pandemic H1N1 influenza A virus infection.
    Ng S; Nachbagauer R; Balmaseda A; Stadlbauer D; Ojeda S; Patel M; Rajabhathor A; Lopez R; Guglia AF; Sanchez N; Amanat F; Gresh L; Kuan G; Krammer F; Gordon A
    Nat Med; 2019 Jun; 25(6):962-967. PubMed ID: 31160818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.